CD44 and neoplasm: To confirm this result, we further analyzed the expression of thymidine kinase 1 (TK-1) or CD44 isoforms in our system, as TK-1 is known to be a tumor proliferation marker [19], and ESRP1 is known to regulate CD44 isoform switching during the EMT [20].